Datafin

Data-driven stock analysis platform for global investors.

Sitemap
HomeScreenerValuationSector Analysis
Resources
LibraryDatafin GuideMetric MethodologyValuation MethodologiesFAQPricingWho Is Datafin?Communication
Legal
Privacy PolicyTerms of UseCookie PolicyKVKK NoticeRefund Policy
Data Sources

Financial data sourced from official regulatory filings and verified market data providers. Metrics calculated using GAAP/IFRS standards.

Disclaimer

The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

Investment decisions involve risk. Verify data independently and consult a licensed advisor when needed.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved.

Last updated: April 2026

AKZA FINANCIAL STATEMENTS

Akzo Nobel NV — balance sheet, income statement and cash flow trends

AKZAAkzo Nobel NV

🇳🇱 Netherlands · AS · Basic Materials · Specialty Chemicals

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income
05 B10 B202120222023202420252026

Profit Funnel

Q1 2026 · TTM
Revenue9.9 B €Gross Profit4 B € · 40%Operating Income830 M € · 8%Pre-tax Income977 M € · 10%Net Income621 M € · 6%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue9.9 B €-7.0%
Gross Profit4 B €-7.4%
Operating Income830 M €-2.6%
EBITDA1.6 B €+24.1%
Net Income621 M €+32.7%

Peer Comparison· Specialty Chemicals

CompanyRev. GrowthGross MarginEBITDA MarginNet Margin
AKZA-7.0%40.1%16.0%6.3%
SOLS————
ESI13.0%40.8%12.0%5.3%
SY124.4%37.9%18.4%6.0%
RPM5.7%41.4%14.9%8.6%
WLK-8.6%1.3%-4.1%-14.9%
Industry median1.2%26.7%14.7%3.5%
CompanyRev. GrowthGross MarginEBITDA MarginNet Margin
AKZA-7.0%40.1%16.0%6.3%
IMCD1.2%17.7%10.9%4.5%
DSFIR-2.7%39.0%18.2%-8.0%
Industry median1.2%26.7%14.7%3.5%

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
05 B10 B15 B202120222023202420252026

Capital Structure

Q1 2026
Total Assets15.5 B
  • Equity4.9 B €32%
  • Current Liabilities4.4 B €29%
  • Long-term Liabilities6 B €39%

Key Figures

YoY change
Total Assets15.5 B €+4.3%
Total Liabilities10.4 B €+4.4%
Total Equity4.9 B €+5.6%
Cash & ST Investments3 B €+71.2%
Total Debt6.1 B €+3.8%
Net Debt3.3 B €-21.9%

Peer Comparison· Specialty Chemicals

CompanyCurrent RatioDebt/EquityNetDebt/EBITDAEquity/Assets
AKZA1.72125.2%1.9431.5%
SOLS1.43162.6%—25.9%
ESI2.6878.9%5.8947.7%
SY12.5270.2%1.4245.9%
RPM2.2892.1%2.2739.9%
WLK2.1775.1%-8.7843.4%
Industry median1.8763.0%2.1546.9%
CompanyCurrent RatioDebt/EquityNetDebt/EBITDAEquity/Assets
AKZA1.72125.2%1.9431.5%
IMCD1.7383.4%2.8144.0%
DSFIR1.5928.9%1.5162.2%
Industry median1.8763.0%2.1546.9%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
0500 M1 B202120222023202420252026

Cash Flow Bridge

Q1 2026 · TTM
0500 M1 B1.5 B956 M €Operating482 M €Investing-235 M €Financing1.2 B €Net Change

Key Figures

YoY change
Operating Cash Flow956 M €+30.8%
Capital Expenditures296 M €-11.9%
Free Cash Flow660 M €+67.1%
Dividends Paid-348 M €-189.0%

Peer Comparison· Specialty Chemicals

CompanyCF MarginFCF MarginCapEx RatioCF/Net Income
AKZA9.6%6.6%3.0%153.9%
SOLS————
ESI7.0%4.3%2.7%132.6%
SY122.4%16.3%5.0%373.4%
RPM10.4%7.5%3.0%121.0%
WLK4.1%-4.6%8.7%-27.4%
Industry median9.6%5.8%5.0%111.7%
CompanyCF MarginFCF MarginCapEx RatioCF/Net Income
AKZA9.6%6.6%3.0%153.9%
IMCD6.7%6.5%0.3%148.1%
DSFIR16.7%9.2%7.5%-210.0%
Industry median9.6%5.8%5.0%111.7%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on AKZA

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.